All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Enhanced pulmonary vasodilator reserve and abnormal right ventricular pulmonary artery coupling in heart failure with preserved ejection fraction

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F15%3A00059621" target="_blank" >RIV/00023001:_____/15:00059621 - isvavai.cz</a>

  • Result on the web

    <a href="http://circheartfailure.ahajournals.org/content/8/3/542.full.pdf+html" target="_blank" >http://circheartfailure.ahajournals.org/content/8/3/542.full.pdf+html</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1161/CIRCHEARTFAILURE.114.002114" target="_blank" >10.1161/CIRCHEARTFAILURE.114.002114</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Enhanced pulmonary vasodilator reserve and abnormal right ventricular pulmonary artery coupling in heart failure with preserved ejection fraction

  • Original language description

    Background Pulmonary hypertension and right ventricular (RV) dysfunction are common in patients with advanced heart failure with preserved ejection fraction (HFpEF), yet their underlying mechanisms remain poorly understood. We sought to examine RV-pulmonary artery (PA) functional reserve responses and RV-PA coupling at rest and during -adrenergic stimulation in subjects with earlier stage HFpEF. Conclusions Pulmonary hypertension in early stage HFpEF is related to partially reversible pulmonary vasoconstriction coupled with RV systolic and diastolic dysfunction, even in the absence of RV structural remodeling. Pulmonary vascular tone is more favorably responsive to -adrenergic stimulation in HFpEF than controls, suggesting a potential role for -agonists in the treatment of patients with HFpEF and pulmonary hypertension. Clinical Trial Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT01418248.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FA - Cardiovascular diseases including cardio-surgery

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Circulation heart failure

  • ISSN

    1941-3289

  • e-ISSN

  • Volume of the periodical

    8

  • Issue of the periodical within the volume

    3

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    9

  • Pages from-to

    542-550

  • UT code for WoS article

    000357079700019

  • EID of the result in the Scopus database